2026 Dean J. Kereiakes: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	134	2119	1973	1197	1098	789	85234

Overview

Dean J. Kereiakes is affiliated with The Christ Hospital Health Network in the United States. Their research is primarily situated within the field of Medicine, focusing on Surgery, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, and Epidemiology.

Their work covers several main topics, including:

Coronary Interventions and Diagnostics
Cardiac Valve Diseases and Treatments
Cardiac Imaging and Diagnostics
Infective Endocarditis Diagnosis and Management
Peripheral Artery Disease Management
Antiplatelet Therapy and Cardiovascular Diseases
Aortic Disease and Treatment Approaches

Frequent co-authors collaborating with Dean J. Kereiakes include Gregg W. Stone, Santiago García, Richard Shlofmitz, Ziad A. Ali, and Puvi Seshiah.

The scientist has contributed extensively to various publication venues, notably:

Journal of the American College of Cardiology
Journal of the Society for Cardiovascular Angiography & Interventions
JACC: Cardiovascular Interventions
Cardiovascular Revascularization Medicine
European Heart Journal

Selected recent publications by Dean J. Kereiakes include:

Principles of Intravascular Lithotripsy for Calcific Plaque Modification, 2021, JACC: Cardiovascular Interventions
Intravascular Lithotripsy for Treatment of Calcified Coronary Lesions, 2021, JACC: Cardiovascular Interventions

Other notable papers where Dean J. Kereiakes is not the lead author but are part of the recent literature include:

Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement, 2020, New England Journal of Medicine
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease, 2020, Journal of the American College of Cardiology
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis, 2021, European Heart Journal

Best Publications

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina)

Eugene Braunwald;Elliott M. Antman;John W. Beasley;Robert M. Califf

8806
Citations
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

Jeffrey W. Moses;Martin B. Leon;Jeffrey J. Popma;Peter J. Fitzgerald

5866
Citations
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

Martin B Leon;Craig R. Smith;Michael J. Mack;Michael J. Mack;Rajendra Makkar

4982
Citations
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article

Eugene Braunwald;Elliott M Antman;John W Beasley;Robert M Califf

2318
Citations
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Laura Mauri;Dean J. Kereiakes;Robert W. Yeh;Priscilla Driscoll-Shempp

2079
Citations
Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease The ONSET/OFFSET Study

Paul A. Gurbel;Kevin P. Bliden;Kathleen Butler;Udaya S. Tantry

1573
Citations
Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

Laurent Bonello;Udaya S. Tantry;Rossella Marcucci;Ruediger Blindt

1373
Citations
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).

Eugene Braunwald;Elliott M Antman;John W Beasley;Robert M Califf

1353
Citations
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial

A. Michael Lincoff;John A. Bittl;Robert A. Harrington;Frederick Feit

1318
Citations
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

James J Ferguson;Robert M Califf;Elliott M Antman;Marc Cohen

1183
Citations
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis

Vinod H. Thourani;Susheel Kodali;Raj R. Makkar;Howard C. Herrmann

1111
Citations
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.

Eric J. Topol;Robert M. Califf;Barry S. George;Dean J. Kereiakes

1090
Citations
Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

Gregg W. Stone;Ali Rizvi;William Newman;Kourosh Mastali

1004
Citations
ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

Jr Smith;J. T. Dove;A. K. Jacobs;J. W. Kennedy

928
Citations
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

Robert W. Yeh;Robert W. Yeh;Eric A. Secemsky;Dean J. Kereiakes;Sharon-Lise T. Normand

914
Citations
ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty) Endorsed by the Society for Cardiac Angiography and Interventions

Sidney C. Smith;James T. Dove;Alice K. Jacobs;J. Ward Kennedy

851
Citations
Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy.

James M. McKenney;Michael J. Koren;Dean J. Kereiakes;Corinne Hanotin

771
Citations
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease

Stephen G. Ellis;Dean J. Kereiakes;D. Christopher Metzger;Ronald P. Caputo

709
Citations
ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)

F. J. Hildner;E. Braunwald;E. M. Antman;J. W. Beasley

91
Citations
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. Commentary

Eric L. Eisenstein;Kevin J. Anstrom;David F. Kong;Linda K. Shaw

9
Citations

Frequent Co-Authors

Gregg W. Stone Icahn School of Medicine at Mount Sinai

Eric J. Topol Scripps Research Institute

Laura Mauri University of Milan

Stephen G. Ellis Cleveland Clinic

Jeffrey J. Popma Beth Israel Deaconess Medical Center

Robert M. Califf Duke University

Donald E. Cutlip Beth Israel Deaconess Medical Center

Patrick W. Serruys University of Galway

A. Michael Lincoff Cleveland Clinic

Alexandra J. Lansky Yale University

External Links

Personal website of Dean J. Kereiakes

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to multiple career pathways beyond becoming a physician. A popular option is health administration, where students can manage healthcare facilities or departments. For those interested, there are affordable online mha programs that provide flexibility and help minimize educational costs.

If advancing clinical skills is your goal, earning a Doctor of Nursing Practice (DNP) or a Doctor of Pharmacy (PharmD) can be beneficial. Many professionals consider the cheapest dnp programs to balance affordability with quality education. PharmD candidates can also now opt for reputable online pharmd pathways that are flexible for working students.

Another expanding field is health information management, which combines technology and healthcare. Earning relevant certifications, such as the RHIA, can boost your career prospects—and there are several rhia certification programs online to consider.

Each option provides strong job prospects and opportunities to specialize within the dynamic world of healthcare, all while allowing you to study from anywhere.